Lymphocytes: not useless after all
http://www.100md.com
《实验药学杂志》
Julie.p.clayton@blueyonder.co.uk
Half a century ago, an immunologist named N. Avrion Mitchison showed that lymphocytes—then thought to be useless—triggered tumor rejection in mice.
Avrion Mitchison says cheers to lymphocytes (1957).
As recently as the 1940s, immunologists thought lymphocytes served no purpose. Antibodies, on the other hand, were all the rage. But this thinking started to change when a British group began to investigate the fate of tissue transplants.
One member of this group was Mitchison, a bright and independent-minded student whose work was inspired by his Oxford University mentor, Peter Medawar. Medawar had discovered that skin grafts given to patients with severe burns survived if derived from the patient's own body, but withered away if taken from a donor. A second graft from the same donor was rejected more quickly than the first. Medawar reproduced this phenomenon in rabbits and—as was customary at the time—believed antibodies to be responsible (1, 2).
Cells become suspects
Intrigued, Mitchison repeated the experiment in mice using tumor transplants instead of skin grafts, because tumors were easier to manipulate. His results were identical to Medawar's—secondary tumors were rejected more rapidly than first-time tumors—but his interpretation was different. Mitchison noticed that the transplanted mice had enlarged lymph nodes, and he recalled a similar observation by Karl Landsteiner and Melvin Chase in guinea pigs vaccinated with a bacterial antigen (3). In that study, the transfer of lymph node cells from vaccinated animals, but not antibody-containing serum, boosted the reaction of naive animals exposed to the antigen.
Mitchison thus wondered whether cells, rather than antibodies, were responsible for the accelerated tumor rejection in his mice. To distinguish between the two possibilities, he transferred either lymph node cells or serum from mice that had already rejected a tumor. Mice that received cells rejected tumors more quickly than both untreated mice and those that received serum, suggesting that the lymph node cells were doing the work (4, 5).
Inspired by Mitchison's finding, Medawar and colleagues Rupert Billingham and Leslie Brent found similar results in rabbits (6). Medawar had "never been that keen on antibodies," recalls Mitchison, "they were simply the only mechanism known at the time. He certainly accepted—gladly—my work".
But questions remained about how the transferred cells acted. Did they attack the tumor directly? Or did they carry tumor antigens with them that prompted a response in the host?
Immunology meets genetics
The effect of the transferred cells disappeared after 10 to 20 days. Mitchison guessed that the host immune system was rejecting the foreign cells and thus switched to a new set of tools—the inbred mice of geneticists Clarence Cook Little and George Snell (Jackson Laboratory, Maine). Bred over many generations, the strains were identical for genes now known as the major histocompatibility complex. This genetic parity allowed transferred lymph node cells to survive for many weeks after transfer without rejection.
Mitchison first confirmed that it was transferred lymphocytes, not antibodies, that led to the quicker tumor rejection in the hosts, as rejection occurred before the hosts could make their own antitumor antibodies. The effect was lost if the cells were killed by freezing before transfer, ruling out the possibility that transferred tumor antigens were the trigger. Mitchison later showed that only the lymph nodes closest to the tumors in donor mice—presumably those collecting and reacting to tumor fragments—contained the tumor-fighting cells.
The already strong case against antibodies was further bolstered when Mitchison showed that serum antibodies, even if transferred with the lymphocytes, were unlikely to reach the tumor transplant. His results, published in three papers in the Journal of Experimental Medicine (7, 8, 9), helped bring immunology to a turning point: the recognition that lymphocytes were important.
The importance of lymphocytes was later solidified by Jim Gowans, who showed that lymphocytes circulated between blood and tissues and therefore could patrol the body (10). Jacques Miller then demonstrated that some lymphocytes developed in the thymus and were essential for fending off infections (11). Mitchison later returned to the UK where he was the first to show convincingly that T and B cells must cooperate to trigger antibody production (12).
References
Medawar, P.B. 1944. J. Anat. 78:176.
Medawar, P.B. 1945. J. Anat. 79:157.
Landsteiner, K., and M.W. Chase. 1942. Proc. Soc. Exp. Biol. 49:688–690.
Mitchison, N.A. 1953. Nature. 171:267–268.
Mitchison, N.A. 1954. Proc. R. Soc. Lond. B. Biol. Sci. 142:72.
Billingham, R.E., L. Brent, and P.B. Medawar. 1954. Proc. R. Soc. Lond. B. Biol. Sci. 143:58.
Mitchison, N.A. 1955. J. Exp. Med. 102:157–177.
Mitchison, N.A. 1955. J. Exp. Med. 102:179–197.
Mitchison, N.A. 1955. J. Exp. Med. 102:199–204.
Gowans, J.L. 1959. J. Physiol. 46:54–69.
Miller, J.F. 1961. Lancet. 2:748–749.
Mitchison, N.A. 2004. Nat. Rev. Immunol. 4:308–312.(Julie Clayton)
婵犵數鍎戠徊钘壝洪悩璇茬婵犻潧娲ら閬嶆煕濞戝崬鏋ゆい鈺冨厴閺屾稑鈽夐崡鐐差潾闁哄鏅滃Λ鍐蓟濞戞ǚ鏋庨煫鍥ㄦ尨閸嬫挻绂掔€n亞鍔﹀銈嗗坊閸嬫捇鏌涢悩宕囥€掓俊鍙夊姇閳规垿宕堕埞鐐亙闁诲骸绠嶉崕鍗炍涘☉銏犵劦妞ゆ帒顦悘锔筋殽閻愬樊鍎旀鐐叉喘椤㈡棃宕ㄩ鐐靛搸婵犵數鍋犻幓顏嗗緤閹灐娲箣閻樺吀绗夐梺鎸庣箓閹峰宕甸崼婢棃鏁傜粵瀣妼闂佸摜鍋為幐鎶藉蓟閺囥垹骞㈤柡鍥╁Т婵′粙鏌i姀鈺佺仩缂傚秴锕獮濠囨晸閻樿尙鐤€濡炪倖鎸鹃崑鐔哥閹扮増鈷戦柛锔诲帎閻熸噴娲Χ閸ヮ煈娼熼梺鍐叉惈閹冲氦绻氶梻浣呵归張顒傜矙閹烘鍊垫い鏂垮⒔绾惧ジ鏌¢崘銊モ偓绋挎毄濠电姭鎷冮崟鍨杹閻庢鍠栭悥鐓庣暦濮椻偓婵℃瓕顦抽柛鎾村灦缁绘稓鈧稒岣块惌濠偽旈悩鍙夋喐闁轰緡鍣i、鏇㈡晜閽樺鈧稑鈹戦敍鍕粶濠⒀呮櫕缁瑦绻濋崶銊у幐婵犮垼娉涢敃銈夊汲閺囩喐鍙忛柣鐔煎亰濡偓闂佽桨绀佺粔鎾偩濠靛绀冩い顓熷灣閹寸兘姊绘担绛嬪殐闁哥姵鎹囧畷婵婄疀濞戣鲸鏅g紓鍌欑劍宀e潡鍩㈤弮鍫熺厽闁瑰鍎戞笟娑㈡煕閺傚灝鏆i柡宀嬬節瀹曟帒顫濋鐘靛幀缂傚倷鐒﹂〃鍛此囬柆宥呯劦妞ゆ帒鍠氬ḿ鎰磼椤旇偐绠婚柨婵堝仱閺佸啴宕掑鍗炴憢闂佽崵濞€缂傛艾鈻嶉敐鍥╃煋闁割煈鍠撻埀顒佸笒椤繈顢橀悩顐n潔闂備線娼уú銈吤洪妸鈺佺劦妞ゆ帒鍋嗛弨鐗堢箾婢跺娲寸€规洏鍨芥俊鍫曞炊閵娿儺浼曢柣鐔哥矌婢ф鏁Δ鍜冪稏濠㈣埖鍔栭崑锝夋煕閵夘垰顩☉鎾瑰皺缁辨帗娼忛妸褏鐣奸梺褰掝棑婵炩偓闁诡喗绮撻幐濠冨緞婢跺瞼姊炬繝鐢靛仜椤曨厽鎱ㄦィ鍐ㄦ槬闁哄稁鍘奸崹鍌炴煏婵炵偓娅嗛柛瀣ㄥ妼闇夐柨婵嗘噹閺嗙喐淇婇姘卞ⅵ婵﹥妞介、鏇㈡晲閸℃瑦顓婚梻浣虹帛閹碱偆鎹㈠┑瀣祦閻庯綆鍠栫粻锝嗙節婵犲倸顏柟鏋姂濮婃椽骞愭惔锝傛闂佸搫鐗滈崜鐔风暦閻熸壋鍫柛鏇ㄥ弾濞村嫬顪冮妶鍡楃瑐闁绘帪绠撳鎶筋敂閸喓鍘遍梺鐟版惈缁夋潙鐣甸崱娑欑厓鐟滄粓宕滃顒夋僵闁靛ň鏅滈崑鍌炴煥閻斿搫孝閻熸瑱绠撻獮鏍箹椤撶偟浠紓浣插亾濠㈣泛鈯曡ぐ鎺戠闁稿繗鍋愬▓銈夋⒑缂佹ḿ绠栭柣鈺婂灠閻g兘鏁撻悩鑼槰闂佽偐鈷堥崜姘额敊閹达附鈷戦悹鍥b偓铏亖闂佸憡鏌ㄦ鎼佸煝閹捐绠i柣鎰綑椤庢挸鈹戦悩璇у伐闁哥噥鍨堕獮鍡涘磼濮n厼缍婇幃鈺呭箵閹烘繂濡锋繝鐢靛Л閸嬫捇鏌熷▓鍨灓缁鹃箖绠栭弻鐔衡偓鐢登瑰暩閻熸粎澧楅悡锟犲蓟濞戙垹绠抽柡鍌氱氨閺嬪懎鈹戦悙鍙夊櫣闂佸府绲炬穱濠囧箻椤旇姤娅㈤梺璺ㄥ櫐閹凤拷Half a century ago, an immunologist named N. Avrion Mitchison showed that lymphocytes—then thought to be useless—triggered tumor rejection in mice.
Avrion Mitchison says cheers to lymphocytes (1957).
As recently as the 1940s, immunologists thought lymphocytes served no purpose. Antibodies, on the other hand, were all the rage. But this thinking started to change when a British group began to investigate the fate of tissue transplants.
One member of this group was Mitchison, a bright and independent-minded student whose work was inspired by his Oxford University mentor, Peter Medawar. Medawar had discovered that skin grafts given to patients with severe burns survived if derived from the patient's own body, but withered away if taken from a donor. A second graft from the same donor was rejected more quickly than the first. Medawar reproduced this phenomenon in rabbits and—as was customary at the time—believed antibodies to be responsible (1, 2).
Cells become suspects
Intrigued, Mitchison repeated the experiment in mice using tumor transplants instead of skin grafts, because tumors were easier to manipulate. His results were identical to Medawar's—secondary tumors were rejected more rapidly than first-time tumors—but his interpretation was different. Mitchison noticed that the transplanted mice had enlarged lymph nodes, and he recalled a similar observation by Karl Landsteiner and Melvin Chase in guinea pigs vaccinated with a bacterial antigen (3). In that study, the transfer of lymph node cells from vaccinated animals, but not antibody-containing serum, boosted the reaction of naive animals exposed to the antigen.
Mitchison thus wondered whether cells, rather than antibodies, were responsible for the accelerated tumor rejection in his mice. To distinguish between the two possibilities, he transferred either lymph node cells or serum from mice that had already rejected a tumor. Mice that received cells rejected tumors more quickly than both untreated mice and those that received serum, suggesting that the lymph node cells were doing the work (4, 5).
Inspired by Mitchison's finding, Medawar and colleagues Rupert Billingham and Leslie Brent found similar results in rabbits (6). Medawar had "never been that keen on antibodies," recalls Mitchison, "they were simply the only mechanism known at the time. He certainly accepted—gladly—my work".
But questions remained about how the transferred cells acted. Did they attack the tumor directly? Or did they carry tumor antigens with them that prompted a response in the host?
Immunology meets genetics
The effect of the transferred cells disappeared after 10 to 20 days. Mitchison guessed that the host immune system was rejecting the foreign cells and thus switched to a new set of tools—the inbred mice of geneticists Clarence Cook Little and George Snell (Jackson Laboratory, Maine). Bred over many generations, the strains were identical for genes now known as the major histocompatibility complex. This genetic parity allowed transferred lymph node cells to survive for many weeks after transfer without rejection.
Mitchison first confirmed that it was transferred lymphocytes, not antibodies, that led to the quicker tumor rejection in the hosts, as rejection occurred before the hosts could make their own antitumor antibodies. The effect was lost if the cells were killed by freezing before transfer, ruling out the possibility that transferred tumor antigens were the trigger. Mitchison later showed that only the lymph nodes closest to the tumors in donor mice—presumably those collecting and reacting to tumor fragments—contained the tumor-fighting cells.
The already strong case against antibodies was further bolstered when Mitchison showed that serum antibodies, even if transferred with the lymphocytes, were unlikely to reach the tumor transplant. His results, published in three papers in the Journal of Experimental Medicine (7, 8, 9), helped bring immunology to a turning point: the recognition that lymphocytes were important.
The importance of lymphocytes was later solidified by Jim Gowans, who showed that lymphocytes circulated between blood and tissues and therefore could patrol the body (10). Jacques Miller then demonstrated that some lymphocytes developed in the thymus and were essential for fending off infections (11). Mitchison later returned to the UK where he was the first to show convincingly that T and B cells must cooperate to trigger antibody production (12).
References
Medawar, P.B. 1944. J. Anat. 78:176.
Medawar, P.B. 1945. J. Anat. 79:157.
Landsteiner, K., and M.W. Chase. 1942. Proc. Soc. Exp. Biol. 49:688–690.
Mitchison, N.A. 1953. Nature. 171:267–268.
Mitchison, N.A. 1954. Proc. R. Soc. Lond. B. Biol. Sci. 142:72.
Billingham, R.E., L. Brent, and P.B. Medawar. 1954. Proc. R. Soc. Lond. B. Biol. Sci. 143:58.
Mitchison, N.A. 1955. J. Exp. Med. 102:157–177.
Mitchison, N.A. 1955. J. Exp. Med. 102:179–197.
Mitchison, N.A. 1955. J. Exp. Med. 102:199–204.
Gowans, J.L. 1959. J. Physiol. 46:54–69.
Miller, J.F. 1961. Lancet. 2:748–749.
Mitchison, N.A. 2004. Nat. Rev. Immunol. 4:308–312.(Julie Clayton)